A brief overview of the key points discussed during a company’s quarterly earnings call, including financial performance, guidance, and management’s commentary on future outlook.
Optomed Earnings
Estimates
Actual
Y-on-Y Change
Revenue
EPS
Transcripts
Events
About Optomed Oyj
O
O
Optomed Oyj
OPTOMED
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland and internationally. It operates in two segments, Devices and Software. The company develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals; and provides professional IT consulting services for government institutions. It offers camera products under the Optomed Smartscope Pro, Optomed Aurora, and Optomed Polaris brand names, as well as OEM cameras under the Pictor Plus and Pictor Prestige (Volk), Visuscout 100 (Zeiss), Fundus Module 300 (The Haag-Streit), and Signal (Topcon) brand names. The company provides Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases; Avenue Archive, an application software for displaying, archiving, and transmitting healthcare information; Avenue Telemedicine, a remote analysis solution; Avenue AI, a diabetic retinopathy screening service; Avenue Sync, a software for integrating fundus camera to the hospital image archive and worklist server; Avenue Flow, an eyecare management software; and Avenue SaaS, a software-as-a-service platform. In addition, it offers Cancer Screen, a screening process management software; Optomed RIS, a software solution for healthcare imaging units; Sectra PACS, a modular system for healthcare providers; Optomed Service Portal, a support function for healthcare units; and Pathology PACS, which allows digital pathology images to be reviewed and shared. It sells its products through OEMs, distributors, and direct sales to hospitals, eye clinics, and optician chains and stores. Optomed Oyj was incorporated in 2004 and is headquartered in Oulu, Finland.
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland and internationally. It operates in two segments, Devices and Software. The company develops, manufactures, and sells fundus cameras for ophthalmologists, pediatrici...
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland and internationally. It operates in two segments, Devices and Software. The company develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals; and provides professional IT consulting services for government institutions. It offers camera products under the Optomed Smartscope Pro, Optomed Aurora, and Optomed Polaris brand names, as well as OEM cameras under the Pictor Plus and Pictor Prestige (Volk), Visuscout 100 (Zeiss), Fundus Module 300 (The Haag-Streit), and Signal (Topcon) brand names. The company provides Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases; Avenue Archive, an application software for displaying, archiving, and transmitting healthcare information; Avenue Telemedicine, a remote analysis solution; Avenue AI, a diabetic retinopathy screening service; Avenue Sync, a software for integrating fundus camera to the hospital image archive and worklist server; Avenue Flow, an eyecare management software; and Avenue SaaS, a software-as-a-service platform. In addition, it offers Cancer Screen, a screening process management software; Optomed RIS, a software solution for healthcare imaging units; Sectra PACS, a modular system for healthcare providers; Optomed Service Portal, a support function for healthcare units; and Pathology PACS, which allows digital pathology images to be reviewed and shared. It sells its products through OEMs, distributors, and direct sales to hospitals, eye clinics, and optician chains and stores. Optomed Oyj was incorporated in 2004 and is headquartered in Oulu, Finland.
Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach. Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
